SAG
CVS icon

SageView Advisory Group’s CVS Health CVS Stock Holding History

SageView Advisory Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$944K Sell
11,900
-3,777
-24% -$298K 0.03% 263
2025
Q3 		$1.18M Buy
15,677
+414
+3% +$28.4K 0.04% 244
2025
Q2 		$910K Buy
15,263
+1,424
+10% +$93.4K 0.03% 258
2025
Q1 		$938K Sell
13,839
-117
-0.8% -$7K 0.04% 237
2024
Q4 		$626K Buy
13,956
+1,739
+14% +$97.6K 0.03% 302
2024
Q3 		$768K Sell
12,217
-2,940
-19% -$172K 0.04% 232
2024
Q2 		$895K Buy
15,157
+625
+4% +$39.1K 0.04% 240
2024
Q1 		$1.16M Sell
14,532
-2,704
-16% -$207K 0.06% 178
2023
Q4 		$1.27M Sell
17,236
-306
-2% -$21.8K 0.05% 214
2023
Q3 		$1.22M Buy
17,542
+1,149
+7% +$81.4K 0.07% 180
2023
Q2 		$1.13M Buy
16,393
+5,855
+56% +$417K 0.06% 201
2023
Q1 		$783K Buy
10,538
+1,243
+13% +$104K 0.05% 247
2022
Q4 		$866K Buy
+9,295
New +$897K 0.07% 170

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SageView Advisory Group's CVS Position: Q4 2025 in Review

SageView Advisory Group reduced its CVS Health (CVS) stake by 24% in Q4 2025, selling an estimated $298K and leaving 11,900 shares worth $944K. The position accounts for 0.03% of the portfolio, ranked #263.

SageView Advisory Group first reported a position in CVS in Q4 2022 and has held it in 13 quarters since. The position peaked at $1.27M in Q4 2023. 1,946 funds tracked by Wall St. Rank hold CVS as of Q4 2025.

  • SageView Advisory Group held 11,900 shares of CVS Health worth $944K as of Q4 2025.
  • SageView Advisory Group sold 3,777 CVS Health shares in Q4 2025, an estimated $298K.
  • CVS Health made up 0.03% of SageView Advisory Group's portfolio in Q4 2025, its #263 holding.
  • SageView Advisory Group first reported a position in CVS Health in Q4 2022 and has held it in 13 quarters since.
  • SageView Advisory Group's CVS Health position peaked at $1.27M in Q4 2023.
  • 1,946 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.

Based on SageView Advisory Group's 13F filing for Q4 2025, filed 17 Feb 2026.